FDA plans to launch Premarket Approval pilot program for high-risk medical devices

Share

emergo-1x1By Stewart Eisenhart, Emergo Group

The US Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) plans to launch a new pilot program to develop a more efficient premarket approval (PMA) market pathway for some high-risk medical devices.

Get the full story here at the Emergo Group’s blog.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MedicalDesignandOutsourcing.com or its employees.

Speak Your Mind

*